JP2022549473A5 - - Google Patents
Info
- Publication number
- JP2022549473A5 JP2022549473A5 JP2022518971A JP2022518971A JP2022549473A5 JP 2022549473 A5 JP2022549473 A5 JP 2022549473A5 JP 2022518971 A JP2022518971 A JP 2022518971A JP 2022518971 A JP2022518971 A JP 2022518971A JP 2022549473 A5 JP2022549473 A5 JP 2022549473A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- trazodone
- salt
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962906166P | 2019-09-26 | 2019-09-26 | |
| US62/906,166 | 2019-09-26 | ||
| PCT/EP2020/077017 WO2021058810A1 (en) | 2019-09-26 | 2020-09-25 | Pediatric trazodone compositions and method of treatment thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022549473A JP2022549473A (ja) | 2022-11-25 |
| JP2022549473A5 true JP2022549473A5 (enExample) | 2023-08-01 |
| JP7629453B2 JP7629453B2 (ja) | 2025-02-13 |
Family
ID=72665264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022518971A Active JP7629453B2 (ja) | 2019-09-26 | 2020-09-25 | 小児用トラゾドン組成物およびその治療法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12514856B2 (enExample) |
| EP (1) | EP4034117A1 (enExample) |
| JP (1) | JP7629453B2 (enExample) |
| KR (1) | KR102936358B1 (enExample) |
| CN (1) | CN114615983A (enExample) |
| AU (1) | AU2020354534B2 (enExample) |
| BR (1) | BR112022005343A2 (enExample) |
| CA (1) | CA3153639A1 (enExample) |
| GE (2) | GEP20257739B (enExample) |
| IL (1) | IL291548A (enExample) |
| MX (1) | MX2022003442A (enExample) |
| UA (1) | UA129270C2 (enExample) |
| WO (1) | WO2021058810A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240173315A1 (en) * | 2022-11-14 | 2024-05-30 | OWP Pharmaceuticals, Inc. | Trazodone oral solution |
| US20240390277A1 (en) * | 2023-04-15 | 2024-11-28 | Rubicon Research Private Limited | Liquid formulations of trazodone |
| CN119280155B (zh) * | 2024-12-11 | 2025-02-25 | 新基元(北京)医药科技有限公司 | 一种改善稳定性的盐酸曲唑酮液体药物组合物及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1931346T1 (sl) | 2005-09-09 | 2012-10-30 | Angelini Labopharm Llc | Trazodonski sestavek za dajanje enkrat dnevno |
| ITMI20071573A1 (it) * | 2007-07-31 | 2009-02-01 | Acraf | Composizione farmaceutica liquida stabile a base di trazodone |
| ITMI20071603A1 (it) | 2007-08-03 | 2009-02-04 | Acraf | Trazodone e trazodone cloridrato in forma purificata |
-
2020
- 2020-09-25 MX MX2022003442A patent/MX2022003442A/es unknown
- 2020-09-25 UA UAA202201314A patent/UA129270C2/uk unknown
- 2020-09-25 AU AU2020354534A patent/AU2020354534B2/en active Active
- 2020-09-25 CA CA3153639A patent/CA3153639A1/en active Pending
- 2020-09-25 GE GEAP202015936A patent/GEP20257739B/en unknown
- 2020-09-25 KR KR1020227011618A patent/KR102936358B1/ko active Active
- 2020-09-25 EP EP20781357.7A patent/EP4034117A1/en active Pending
- 2020-09-25 JP JP2022518971A patent/JP7629453B2/ja active Active
- 2020-09-25 WO PCT/EP2020/077017 patent/WO2021058810A1/en not_active Ceased
- 2020-09-25 BR BR112022005343A patent/BR112022005343A2/pt unknown
- 2020-09-25 GE GEAP202415936A patent/GEAP202415936A/en unknown
- 2020-09-25 CN CN202080066712.7A patent/CN114615983A/zh active Pending
- 2020-09-25 US US17/763,037 patent/US12514856B2/en active Active
-
2022
- 2022-03-21 IL IL291548A patent/IL291548A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2891494B1 (en) | Method for administering hypnotic/sedative agent | |
| US7022687B1 (en) | Combination of loteprednol and antihistamines | |
| BR112020012473A2 (pt) | escetamina para o tratamento da depressão | |
| EA022040B1 (ru) | Применение бетанехола для лечения ксеростомии | |
| BR122014001142A2 (pt) | Formulação purgativa colônica, kit, método de purgar o cólon de um paciente, e, processo de produzir a formulação purgativa colônica | |
| DK2387389T3 (en) | Composition for oral transmucosal administration of analgesic or antispasmodic molecules | |
| NO336916B1 (no) | Farmasøytisk blanding for intranasal administrering og anvendelse derav, samt en innretning for intranasal levering | |
| EA008165B1 (ru) | Композиции для лечения простуды | |
| US12343338B2 (en) | Ramipril solution for oral dosage | |
| JP2013541583A (ja) | 組み合わせ組成物 | |
| CN116265011A (zh) | 布瓦西坦口服液制备及其制备方法 | |
| CN106727291A (zh) | 一种盐酸托莫西汀口服溶液及其制备方法 | |
| CN107362141A (zh) | 一种盐酸羟甲唑啉鼻喷雾剂及其制备方法 | |
| CN116472033A (zh) | 用于经鼻施用的钴胺素化合物的药物组合物 | |
| JP2007508313A (ja) | メチルフェニデート溶液および関連する投与および製造方法 | |
| AU2014220339B2 (en) | Oral formulation and suspension of an oncology drug | |
| ES2995007T3 (en) | Polymers, compositions and methods for treating hyperuricemia | |
| CN109646438A (zh) | 去甲乌药碱或其盐酸盐在制备治疗鼻炎药物中的应用 | |
| JP2024539923A (ja) | 唾液分泌過多症を治療するための組成物及び方法 | |
| CN115607545A (zh) | 依达拉奉在自闭症谱系障碍治疗中的应用 | |
| WO2022115681A2 (en) | Methods and compositions for oral pilocarpine liquid | |
| RU2134114C1 (ru) | Способ лечения гнойных гайморитов | |
| CN100408043C (zh) | 一种含虎杖苷的药物组合物及其应用 | |
| WO2020240279A1 (en) | Intranasal administration of ketamine to cluster headache patients | |
| EA036752B1 (ru) | Способ получения геля для ректального и наружного применения, включающего нифедипин и лидокаина гидрохлорид (варианты) |